Reporter July 29 2022
Targeted cancer drug during pregnancy
Aug. 2, 2022—The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians.
H. pylori and lung cancer
Aug. 1, 2022—Specific biomarkers for H. pylori — a bacterium that infects the stomach — were associated with increased risk of lung cancer, Vanderbilt researchers have discovered.
Video vital for telehealth visits
Jul. 28, 2022—Vanderbilt study of 18,130 telehealth visits at the beginning of the COVID-19 pandemic defines risk factors associated with telehealth access and suggests how health systems can improve access.
Specialty pharmacists help reduce MS relapse risk
Jul. 28, 2022—Just one-third of patients with relapsing multiple sclerosis remain on disease-modifying therapy, and specialty pharmacists are in a unique position to help coordinate therapy discontinuation or change and reduce the risk of relapse.
White Coat Ceremony marks start of medical school journey
Jul. 28, 2022—Vanderbilt University School of Medicine welcomed 96 first-year students on Friday, July 22, during its annual White Coat Ceremony.
C. difficile may contribute to colorectal cancer: study
Jul. 28, 2022—A Vanderbilt study found that the bacterium Clostridioides difficile (C. difficile) may be a previously unrecognized contributor to colorectal cancer.
Study to evaluate nasal flu vaccine for children
Jul. 28, 2022—Pediatricians with the Vanderbilt Vaccine Research Program are looking for healthy infants and children (6 months – 8 years of age) to take part in a nasal influenza vaccine study.
Patient doing well after complex vascular procedures
Jul. 28, 2022—Marsha Eastridge had no clue she had heart problems until she was diagnosed in December 2021. Barely three weeks later, she was undergoing the first of two complex vascular procedures at Vanderbilt Heart and Vascular Institute that would save her life.
Study reveals need for matching targeted therapies with EGFR subtypes
Jul. 28, 2022—A Vanderbilt study suggests that clinicians should take a deeper dive into distinguishing EGFR mutations when prescribing targeted therapies for non-small-cell lung cancers.
Partnership creates new pharmacy informatics fellowship
Jul. 28, 2022—Vanderbilt has partnered with a leading provider of medication management solutions and adherence tools for health systems and pharmacies to create a new two-year pharmacy informatics fellowship.
Increase seen in children ingesting THC-infused edibles
Jul. 28, 2022—Clinicians at Monroe Carell Jr. Children’s Hospital at Vanderbilt are seeing an increase in the number of young children requiring treatment after ingesting THC-infused products.
Vanderbilt University Medical Center again named to ‘Honor Roll’ of nation’s finest hospitals
Jul. 26, 2022—Vanderbilt University Medical Center has again been named to the Honor Roll of America’s Best Hospitals by U.S. News & World Report in the publication’s 2022-2023 ranking of health care facilities.